Antitumor and immunologic effects of a pyridine-extracted fraction of Propionibacterium acnes

Area of Science:

• Immunology
• Microbiology
• Oncology

Background:

• Tumor rejection in the murine ovarian teratocarcinoma (MOT) model relies on sequential activation of tumoricidal neutrophils (PMNs) and cytostatic macrophages.
• Propionibacterium acnes is known to modulate immune responses.

Purpose of the Study:

• To evaluate the antitumor and immunological effects of a pyridine extractable fraction of Propionibacterium acnes in a murine ovarian teratocarcinoma (MOT) model.
• To investigate the role of neutrophils and macrophages in the observed antitumor activity.

Main Methods:

• Testing a pyridine extractable fraction of Propionibacterium acnes in a murine ovarian teratocarcinoma (MOT) model.
• Challenging mice with varying inocula (10(3), 10(4), 10(5)) of MOT cells.
• Assessing survival rates, in vivo cytoreduction, and immune cell infiltration (PMNs, macrophages).
• Evaluating Natural Killer (NK) cell cytotoxicity.

Main Results:

• The pyridine extract significantly prolonged survival in mice challenged with 10(3) or 10(4) MOT cells, but not with 10(5) cells.
• In vivo cytoreduction within 24 hours correlated with PMN influx.
• Immunotherapy failure occurred when macrophage chemotaxis was initiated (48-72 hours) for higher tumor loads.
• The extract enhanced NK cytotoxicity on day 5 but depressed it on day 1.
• The extract retained neutrophil-activating moieties but lacked macrophage-activating determinants.

Conclusions:

• The pyridine extract of Propionibacterium acnes demonstrates antitumor activity mediated by neutrophils against low tumor burdens.
• The depletion of macrophage-activating components in the extract limits its efficacy against larger tumor inocula.
• The findings highlight the differential roles of neutrophils and macrophages in this model and the extract's immunomodulatory properties.